D.A. Davidson & Co’s Spero Therapeutics SPRO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-10,800
| Closed | -$8K | – | 1325 |
|
|
2022
Q2 | $8K | Sell |
10,800
-33,000
| -75% | -$24.4K | ﹤0.01% | 1262 |
|
|
2022
Q1 | $381K | Hold |
43,800
| – | – | ﹤0.01% | 983 |
|
|
2021
Q4 | $701K | Buy |
43,800
+800
| +2% | +$12.8K | 0.01% | 764 |
|
|
2021
Q3 | $792K | Buy |
43,000
+9,000
| +26% | +$166K | 0.01% | 699 |
|
|
2021
Q2 | $475K | Buy |
34,000
+500
| +1% | +$6.99K | 0.01% | 850 |
|
|
2021
Q1 | $493K | Buy |
33,500
+3,500
| +12% | +$51.5K | 0.01% | 812 |
|
|
2020
Q4 | $582K | Buy |
30,000
+500
| +2% | +$9.7K | 0.01% | 656 |
|
|
2020
Q3 | $329K | Buy |
29,500
+7,700
| +35% | +$85.9K | 0.01% | 748 |
|
|
2020
Q2 | $295K | Buy |
21,800
+6,800
| +45% | +$92K | 0.01% | 756 |
|
|
2020
Q1 | $121K | Hold |
15,000
| – | – | ﹤0.01% | 919 |
|
|
2019
Q4 | $144K | Buy |
15,000
+3,000
| +25% | +$28.8K | ﹤0.01% | 973 |
|
|
2019
Q3 | $127K | Buy |
12,000
+2,000
| +20% | +$21.2K | ﹤0.01% | 947 |
|
|
2019
Q2 | $115K | Buy |
+10,000
| New | +$115K | ﹤0.01% | 947 |
|